SCHEMBL7516433

SCHEMBL7516433

CC(C)S(=O)(=O)Nc1ccc2nc(C(O)c3ccc(Oc4ccccc4)cc3)[nH]c2c1

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 7/20 0.66
GRIN2B Q13224 7/20 0.66
MLKL Q8NB16 3/20 0.46
PTGES O14684 1/20 0.43
ALOX5 P09917 1/20 0.43
LTC4S Q16873 1/20 0.43
KDR P35968 1/20 0.41
TEK Q02763 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHEK2 O96017 2/20 0.40
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
PDE10A Q9Y233 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511793 0.90 GRIN1 (0.63) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7517060 0.88 GRIN1 (0.65) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7508541 0.79 GRIN1 (0.57) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7511185 0.72 GRIN1 (0.87) GRIN1GRIN2BMAPTSMN1; SMN2
SCHEMBL4235689 0.70 GRIN1 (0.54) GRIN1GRIN2BTP53MAPTSMN1; SMN2
SCHEMBL24953738 0.70 KDM4E (0.60) GRIN1GRIN2BPTGESALOX5LTC4S
SCHEMBL31206946 0.70 KDM4E (0.60) GRIN1GRIN2BPTGESALOX5LTC4S
SCHEMBL7512484 0.69 GRIN1 (0.64) GRIN1GRIN2BCHEK2PDE10A
SCHEMBL4235685 0.69 GRIN1 (0.50) GRIN1GRIN2BMLKLSMN1; SMN2CHEK2
SCHEMBL7452878 0.67 GRIN1 (1.00) GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed